News Daily News PolyIran: Polypill Prevents Major Cardiovascular Events Over 5 Years Todd Neale August 23, 2019
News Daily News Ezetimibe With Statin Therapy: Biggest Bang in Higher-Risk ACS Patients Michael O'Riordan August 22, 2019
News Daily News New AHA Guidance on Omega-3 Fatty Acids for High Triglycerides Michael O'Riordan August 21, 2019
News Daily News A Boost for Prescription Omega-3s? Not Yet: FDA Panel Set for November Yael L. Maxwell August 14, 2019
News Daily News Trial Points to Possible Benefit of Intensive BP-Lowering to Stave Off Recurrent Stroke Todd Neale July 29, 2019
News Daily News DOACs Good for Secondary Prevention in Older A-fib Patients, Real-world Numbers Affirm Todd Neale July 23, 2019
News Daily News Silent MI Often Precedes Sudden Cardiac Death, Finnish Data Confirm Caitlin E. Cox July 15, 2019
News Daily News Clopidogrel-Aspirin in Minor Stroke/TIA of Maximum Benefit in First 21 Days Todd Neale July 09, 2019
News Daily News Most Supplements and Diets Don’t Lower CVD or Mortality Risks Michael O'Riordan July 09, 2019
News Daily News Weight Training, Aerobic Exercise Affect Cardiac Fat Mass in Different Ways Michael O'Riordan July 05, 2019
News Daily News Hybrid Revascularization for Multivessel CAD Rarely Used in the US Todd Neale July 04, 2019
News Daily News Which ASCVD Patients Will Benefit Most From Rivaroxaban Plus Aspirin? Some Clues Todd Neale June 26, 2019
Presentation TVT 2019 Operator and Institutional Requirements for PFO Closure for Secondary Prevention of Paradoxical Embolic Stroke Presenter: Zahid Amin June 14, 2019
Presentation TVT 2019 PFO Closure for Secondary Prevention of Paradoxical Embolic Stroke: Randomized Trial Synthesis Presenter: Fabian Nietlispach June 14, 2019
News Daily News CAD’s Genetic Basis Strongly Overlaps With Other Vascular Conditions and Risk Factors Caitlin E. Cox June 12, 2019
News Conference News EAS 2019 FH Patients Derive Biggest Absolute Benefit From Statin Therapy: 4S Analysis Michael O'Riordan June 03, 2019
News Conference News EAS 2019 Bempedoic Acid/Ezetimibe Combo Lowers LDL Cholesterol in High-Risk Patients Michael O'Riordan May 30, 2019
News Conference News EAS 2019 Clear CVD Risk Reduction With PCSK9 Inhibitors, but No Mortality Effect: Meta-analysis Michael O'Riordan May 28, 2019